FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to pharmaceutical industry and represents a pharmaceutical composition for topical administration comprising the active ingredients in the form of 0.001-5.0 wt % of deoxyribonuclease (DNA-ase) and 0.001-5.0 wt % of glycyrrhizinic acid or a salt thereof: ammonium or dipotassium or trisodium glycyrrhizinate, as carriers: β-cyclodextrins 0.001-5.0 wt % and pharmaceutically acceptable carriers or excipients, which may be used in medicine for treating and preventing viral infections caused by DNA-containing viruses, such as herpes simplex, herpes zoster, human papilloma.
EFFECT: invention provides improved stability, potentiated complex antiviral effect.
2 cl, 6 ex
Authors
Dates
2013-07-10—Published
2012-03-01—Filed